Open NowBusiness
Biomedical Translation Fund — Australia, 2025-26
Rolling Applications
Australian Government
The Biomedical Translation Fund provides equity co-investment venture capital to early-stage biomedical companies through licensed private sector fund managers. It supports the development and commercialisation of biomedical discoveries into products, services and health outcomes.
Deadline
Rolling / Ongoing
Location
Australia
Who Can Apply
• Must be a company seeking equity investment under the Biomedical Translation Fund
• Must be early-stage and working on, or planning to work on, a biomedical discovery through BTF investment
• Should have a majority of employees and assets inside Australia, or plan to use the whole of the initial investment within Australia
• Must have average annual revenue over the previous two years below $25 million per year
• Must have an Australian business number (ABN)
• Must be incorporated under the Corporations Act 2001
• Must provide all goods or services produced to persons who are not Associates
• Eligibility and investment decisions are determined by licensed private sector fund managers
• Not all eligible companies will receive investment
At the time of the first investment, the company must either already be working on a biomedical discovery or plan to work on a biomedical discovery through a BTF investment. The company should either have a majority of its employees and assets inside Australia or plan to use the whole of the initial investment within Australia. It must also have average annual revenue over the previous two years below $25 million per year, have an Australian business number, be incorporated under the Corporations Act 2001, and provide all goods or services it produces to persons who are not Associates. Investment decisions are made by 3 licensed private sector fund managers, and not all eligible companies will receive investment.
What's Funded
Equity-funded activities to develop and commercialise biomedical discoveries, including therapeutic, medical, pharmaceutical, digital health, product, process, service, technology or procedure development.Before you apply
Check Biomedical Translation Fund fit and evidence gaps
Use this business grant page to sanity-check eligibility, funding fit, evidence gaps and application effort before you commit days to drafting. If you already know the grant you want, the 48-hour audit gives a practical go/no-go view, reviewer-readiness score and next-step risks.
Get a 48-hour grant fit auditExpected Outcomes
Commercialised biomedical discoveries, growth of Australian biomedical companies, and improved health and wellbeing outcomes through prevention, diagnosis and treatment innovations.Key Information
Applicant Types
company
Stage
early_stage
Funding Purposes
commercialisationinnovationresearch
Keywords
biomedicalventure capitalequity investmentcommercialisationhealth and medical researchdigital healthmedical technologypharmaceutical
Frequently Asked Questions
1
What is the Biomedical Translation Fund?
The Biomedical Translation Fund is a business grant offered by Australian Government in Australia. The Biomedical Translation Fund provides equity co-investment venture capital to early-stage biomedical companies through licensed private sector fund managers. It supports the development and commercialisation of biomedical discoveries into products, services and health outcomes.
2
Who is eligible for the Biomedical Translation Fund?
- Must be a company seeking equity investment under the Biomedical Translation Fund
- Must be early-stage and working on, or planning to work on, a biomedical discovery through BTF investment
- Should have a majority of employees and assets inside Australia, or plan to use the whole of the initial investment within Australia
- Must have average annual revenue over the previous two years below $25 million per year
- Must have an Australian business number (ABN)
- Must be incorporated under the Corporations Act 2001
- Must provide all goods or services produced to persons who are not Associates
- Eligibility and investment decisions are determined by licensed private sector fund managers
- Not all eligible companies will receive investment
3
What activities are funded?
Equity-funded activities to develop and commercialise biomedical discoveries, including therapeutic, medical, pharmaceutical, digital health, product, process, service, technology or procedure development.
4
How do I apply for the Biomedical Translation Fund?
Start by checking your eligibility using the free Beta Docs eligibility checker. If eligible, Beta Docs' AI-powered platform can help you draft, review, and refine your application to maximise your chances of success.
Need help applying?
Beta Docs has helped founders secure $160M+ in competitive grants. Our AI platform drafts compliance-perfect applications — and our expert reviewers make sure you stand out.